Company Overview and News

 
Threat to profit margins and earnings from higher crude oil prices

2018-05-21 livemint
Brent crude oil prices flirting with $80 a barrel cannot be taken lightly. Among other macro worries such as a rising import bill and higher inflation, there is a threat to operating profit margins of companies that use oil, oil-based derivatives or fuel as inputs.

 
Jet Airways planning follow-on deal for Boeing 737 Max

2018-05-18 livemint
Manchester, England: Jet Airways India Ltd. is closing in on a new order for Boeing Co.’s 737 Max single-aisle plane that could take its commitments for the model above 200 aircraft.

 
Wow! The Cheapest Airfare to New York From Delhi Is Via Iceland - Bloomberg

2018-05-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Closing Bell: Sensex ends flat, midcaps melt amid uncertainty over Karnataka election results

2018-05-15 moneycontrol
Market Closing: Benchmark indices ended flat after the BJP is likely to fail to reach half-way mark in Karnataka, though it is likely to be emerging as the largest party with 104 seats.

 
Market Live: Sensex in the red, rupee sinks 35 paise; BJP leads in Karnataka but away from half-way mark

2018-05-15 moneycontrol
Earnings: Pharma major Lupin has posted a loss of Rs 783.5 crore for the quarter ended March 2018, due to one-time loss of Rs 1,464.3 crore on Gavis Group acquisition.

 
Wow Air offers cheapest fare to New York from Delhi

2018-05-15 livemint
New Delhi: For millions of Indians flying West every year, there’s a new airline in town. And, it’s ultra cheap.

 
Market Live: Sensex off day#39;s high, midcaps weak; BJP leads in Karnataka but away from half-way mark

2018-05-15 moneycontrol
Market Update: The market lost more than 3/4th of its gains in afternoon trade. The BJP is likely to emerge as the single largest party in the Karnataka Assembly as it leads in 106 constituencies but is slightly away from its half-way mark.

 
Four cos added to MSCI India index

2018-05-15 moneycontrol
As many as four companies - Avenue Supermarts, Biocon, HDFC Standard Life Insurance Company and InterGlobe Aviation - will be added to the MSCI India Index with effect from June 1. The news triggered buying in most of these companies, with shares of Avenue Supermarts surging 6.5 percent to Rs 1,516.80 on BSE.

 
Market Live: Sensex up 400 pts, Nifty above 10,900 as BJP ups lead over Congress in Karnataka

2018-05-15 moneycontrol
Acquisition: Kopran Research Laboratories, a wholly owned subsidiary of Kopran, has purchased API facility of Maxheal Pharmaceuticals India at Panoli, Gujarat.

 
Market Live: Sensex up 275 pts, Nifty inches towards 10,900 as BJP leads in Karnataka

2018-05-15 moneycontrol
Emkay on CPI Inflation: After a softening trend of inflation in Q4FY18, Apr’18 witnessed a sharp reversal in overall inflation, both at wholesale and retail levels. CPI inflation rose to 4.6 percent while WPI too picked up momentum with 3.2 percent print.

 
SpiceJet stock generates mixed interest among brokerages

2018-05-14 thehindubusinessline
Elara is bullish on SpiceJet as it has pegged a target price of ₹203 on the stock, which implies an upside potential of 71 per cent from current levels.

 
Eyes on MSCI rejig: Will Pidilite make an entry?

2018-05-14 thehindubusinessline
MSCI Inc, in its semi-annual review, will announce changes in indices on Tuesday. Analysts expect some of these stocks — PowerGrid, Pidilite Industries, Avenue Supermart, Future Retail, HDFC Standard Life Insurance, and Interglobe Aviation, to enter the MSCI Global Standard index. Tata Motor (DVR) and Vakrangee may be excluded, while the weightage of UltraTech Cement and Concor may increase, marketmen feel.

 
InterGlobe Aviation: Turbulent times

2018-05-06 premium.thehindubusinessline
A lot can happen over a week in Indian aviation. Or so it seems from the sharp dip in fortunes of market leader InterGlobe Aviation (IndiGo Airlines) and its stock on the bourses. From peak levels of ₹1,500 on April 26, the stock is down about 27 per cent. This follows unexpected bad news — first, the exit of top executive Aditya Ghosh and, next, the dismal results posted by the company in the March 2018 quarter with profits crashing about 73 per cent y-o-y.

 
Airline shares face turbulence; Jet, IndiGo stocks tumble up to 20% in 3 days

2018-05-06 thehindubusinessline
Stocks of airlines have hit some air pockets, slumping up to 20 per cent in just three trading sessions this month amid rising fuel costs and weak quarterly earnings of InterGlobe Aviation impacting investor sentiment.

 
IndiGo scrips plummet 10% on weak Q4 earnings

2018-05-04 freepressjournal.in
New Delhi : Shares of InterGlobe Aviation ended sharply lower by 10 per cent on Thursday, wiping out Rs 5,475 crore from its market valuation, after the company reported a 73 per cent plunge in profit for the March quarter.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

21h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

21h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...